MiniMed Group, Inc. (MMED)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 04-24. Amounts in USD.

Revenue Quarterly

0 300M 600M 900M Q3 '25: 687M Q4 '25: 724M Q3 '26: 790M Q4 '26: 837M Q3 '25 Q4 '25 Q3 '26 Q4 '26

Gross Profit Quarterly

0 200M 400M 600M Q3 '25: 395M Q4 '25: 405M Q3 '26: 362M Q4 '26: 480M Q3 '25 Q4 '25 Q3 '26 Q4 '26

Operating Income Quarterly

-180M -120M -60M 0 60M 120M 180M Q3 '25: 21M Q4 '25: -148M Q3 '26: -100M Q4 '26: -93M Q3 '25 Q4 '25 Q3 '26 Q4 '26

Net Income Quarterly

-210M -140M -70M 0 70M 140M 210M Q1 '25: -19M Q2 '25: -5M Q3 '25: -10M Q4 '25: -172M Q1 '26: -16M Q2 '26: -5M Q3 '26: -119M Q4 '26: -185M Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26

Cost of Revenue Quarterly

0 150M 300M 450M Q3 '25: 292M Q4 '25: 318M Q3 '26: 428M Q4 '26: 357M Q3 '25 Q4 '25 Q3 '26 Q4 '26

Operating Cash Flow Quarterly

-180M -120M -60M 0 60M 120M 180M Q4 '25: 83M Q4 '26: -170M Q4 '25 Q4 '26

Free Cash Flow Quarterly

-240M -160M -80M 0 80M 160M 240M Q4 '25: 26M Q4 '26: -226M Q4 '25 Q4 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 90M 180M 270M Q3 '25: 252.8M Q3 '26: 252.8M Q3 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.